Awarded contract

Published

Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1)

6 suppliers have saved this notice.

Looks like a fit? Save this tender and qualify it in Stotles

Value

1,677,290 GBP

Current supplier

Revvity (UK) Limited

Description

Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card. The blood sample is analysed by one of 13 newborn screening laboratories in England

Never miss a tender again

Get alerts, AI summaries and tools to qualify faster

Explore similar pre-tenders, open or awarded contracts

Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.

NHS Blood and Transplant

167,410 GBP

Published 2 months ago

NHS Blood and Transplant

29,800,000 GBP

Published 5 months ago

Leeds Teaching Hospitals NHS Trust

191,700 GBP

Published 5 months ago

Procurement and Logistics Service, Procurement and Logistics Service on behalf of the Belfast Health and Social Care Trust.

1,725,705.48 GBP

Published 5 months ago

HSC Business Services Organisation

16,932,019.1 GBP

Published 5 months ago

Yorkshire Ambulance Service NHS Trust

140,309.51 GBP

Published 5 months ago

Nuclear Restoration Services Limited

243,333 GBP

Published 5 months ago

Nuclear Restoration Services Limited

243,000 GBP

Published 5 months ago

NHS Blood and Transplant

162,530 GBP

Published a year ago

Sign up to the Stotles Tender Tracker for free

Find even more contracts with advanced search capability and AI powered relevance scoring.